Trends in the postfortification prevalence of spina bifida and anencephaly in the United States

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 82, Issue 7, 2008, Pages 527-532

  Boulet, Sheree L ^a   Yang, Quanhe ^a   Mai, Cara ^a   Kirby, Russell S ^b   Collins, Julianne S ^c   Robbins, James M ^d   Meyer, Robert ^e   Canfield, Mark A ^f   Mulinare, Joe ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c GREENWOOD GENETIC CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^e North Carolina Center for Nursing   (United States)

^f TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

Author keywords

Anencephaly; Folic acid; Fortification; Neural tube defects; Spina bifida

Indexed keywords

ANENCEPHALUS; ARTICLE; BIRTH DEFECT; DIET SUPPLEMENTATION; ETHNICITY; HISPANIC; HUMAN; INFANT; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SPINA BIFIDA; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANENCEPHALY; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLIC ACID; FOOD, FORTIFIED; HISPANIC AMERICANS; HUMANS; INFANT, NEWBORN; POPULATION SURVEILLANCE; PREVALENCE; SPINAL DYSRAPHISM; UNITED STATES;

EID: 47749142440     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20468     Document Type: Article

References (36)

1. Becerra JE, Khoury MJ, Cordero JF, et al. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9.
2. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
3. Besser LM, Williams LJ, Cragan JD. 2007. Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long-term trends, Atlanta, Georgia, 1968-2003. Birth Defects Res A Clin Mol Teratol 79:730-736.
4. Cabrera RM, Hill DS, Etheredge AJ, et al. 2004. Investigations into the etiology of neural tube defects. Birth Defects Res C Embryo Today 72:330-344.
5. Canfield MA. 1996. Hispanic origin and neural tube defects in Houston/Harris County, Texas. I. Descriptive epidemiology. Am J Epidemiol 143:1-11.
6. Canfield MA, Honein MA, Yuskiv N, et al. 2006. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 76:747-756.
7. CDC. 1992a. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41:1-6.
8. CDC. 1992b. Spina bifida incidence at birth-United States, 1983-1990. MMWR 41:497-500.
9. CDC. 2004. Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR 53:362-365.
10. CDC. 2005. Use of dietary supplements containing folic acid among women of childbearing age-United States, 2005. MMWR 54:955-958.
11. CDC. 2007. Folate status in women of childbearing age, by race/ethnicity - United States, 1999-2000, 2001-2002, and 2003-2004. MMWR 55:1377-1380.
12. Cowie CC, Rust KF, Byrd-Holt DD, et al. 2006. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. Diabetes Care 29:1263-1268.
13. Cragan JD, Roberts HE, Edmonds LD, et al. 1995. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR 44:1-13.
14. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
15. Esfahani ST, Cogger EA, Caudill MA. 2003. Heterogeneity in the prevalence of methylenetetrahydrofolate reductase gene polymorphisms in women of different ethnic groups. J Am Diet Assoc 103:200-207.
16. Food and Drug Administration. 1996. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 61:8781-8797.
17. Green-Raleigh K, Carter H, Mulinare J, et al. 2006. Trends in folic Acid awareness and behavior in the United States: the Gallup organization for the march of dimes foundation surveys, 1995-2005. Matern Child Health J 10 Suppl 7:177-182.
18. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 285:2981-2986.
19. Johnston KE, Tamura T. 2004. Folate content in commercial white and whole wheat sandwich breads. J Agric Food Chem 52:6338-6340.
20. Khoury MJ, Erickson JD, James LM. 1982. Etiologic heterogeneity of neural tube defects: clues from epidemiology. Am J Epidemiol 115:538-548.
21. Mathews T J, Honein M A, Erickson J D. 2002. Spina bifida and anencephaly prevalence - United States, 1991-2001. MMWR 51:9-11.
22. MRC. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338:131-137.
23. National Birth Defects Prevention Network. 2004. Guidelines for Conducting Birth Defects Surveillance. In: Sever LE, editor. Atlanta, GA: National Birth Defects Prevention Network, Inc.
24. Ogden CL, Carroll MD, Curtin LR, et al. 2006. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295:1549-1555.
25. Peller AJ, Westgate MN, Holmes LB. 2004. Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination. Obstet Gynecol 104:957-964.
26. Pfeiffer CM, Johnson CL, Jain RB, et al. 2007. Trends in blood folate and Vitamin B-12 concentration in the United States, 1988-2004. Am J Clin Nutr 86:718-727.
27. Quinlivan EP, Gregory JF. 2007. Reassessing folic acid consumption patterns in the United States (1999-2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 86:1773-1779.
28. Ray JG, Vermeulen MJ, Meier C, et al. 2004. Maternal ethnicity and risk of neural tube defects: a population-based study. CMAJ 171:343-345.
29. Schechtman KB, Gray DL, Baty JD, et al. 2002. Decision-making for termination of pregnancies with fetal anomalies: analysis of 53,000 pregnancies. Obstet Gynecol 99:216-222.
30. Sever LE. 1995. Looking for Causes of Neural Tube Defects: Where does the environment fit in? Environmental Health Perspectives 103(Suppl 6):165-171.
31. Shaw GM, Velie EM, Wasserman CR. 1997. Risk for neural tube defect-affected pregnancies among women of Mexican descent and white women in California. Am J Public Health 87:1467-1471.
32. Velie EM, Shaw GM. 1996. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am J Epidemiol 144:473-479.
33. Waller DK, Shaw GM, Rasmussen SA, et al. 2007. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med 161:745-750.
34. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66:33-39.
35. Williams LJ, Rasmussen SA, Flores A, et al. 2005. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 116:580-586.
36. Yang QH, Carter HK, Mulinare J, et al. 2007. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 85:1409-1416.